PL1762238T3 - Połączenie agomelatyny z regulatorem nastroju oraz zawierające je kompozycje farmaceutyczne - Google Patents

Połączenie agomelatyny z regulatorem nastroju oraz zawierające je kompozycje farmaceutyczne

Info

Publication number
PL1762238T3
PL1762238T3 PL06291423T PL06291423T PL1762238T3 PL 1762238 T3 PL1762238 T3 PL 1762238T3 PL 06291423 T PL06291423 T PL 06291423T PL 06291423 T PL06291423 T PL 06291423T PL 1762238 T3 PL1762238 T3 PL 1762238T3
Authority
PL
Poland
Prior art keywords
agomelatine
association
pharmaceutical compositions
mood stabilizer
mood
Prior art date
Application number
PL06291423T
Other languages
English (en)
Inventor
Bodinat Christian De
Original Assignee
Servier Lab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=36190792&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=PL1762238(T3) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Servier Lab filed Critical Servier Lab
Publication of PL1762238T3 publication Critical patent/PL1762238T3/pl

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/16—Amides, e.g. hydroxamic acids
    • A61K31/165—Amides, e.g. hydroxamic acids having aromatic rings, e.g. colchicine, atenolol, progabide
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C231/00—Preparation of carboxylic acid amides
    • C07C231/08—Preparation of carboxylic acid amides from amides by reaction at nitrogen atoms of carboxamide groups
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/21—Esters, e.g. nitroglycerine, selenocyanates
    • A61K31/215—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids
    • A61K31/22—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids of acyclic acids, e.g. pravastatin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/08—Antiepileptics; Anticonvulsants
    • A61P25/10—Antiepileptics; Anticonvulsants for petit-mal
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/08—Antiepileptics; Anticonvulsants
    • A61P25/12—Antiepileptics; Anticonvulsants for grand-mal
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/20—Hypnotics; Sedatives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/24—Antidepressants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
PL06291423T 2005-09-09 2006-09-08 Połączenie agomelatyny z regulatorem nastroju oraz zawierające je kompozycje farmaceutyczne PL1762238T3 (pl)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
FR0509208A FR2890563B1 (fr) 2005-09-09 2005-09-09 Nouvelle association entre l'agomelatine et un agent thymoregulateur et les compositions pharmaceutiques qui la contiennent
EP06291423A EP1762238B1 (fr) 2005-09-09 2006-09-08 Association entre l'agomélatine et un agent thymorégulateur et compositions pharmaceutiques les contenant

Publications (1)

Publication Number Publication Date
PL1762238T3 true PL1762238T3 (pl) 2011-12-30

Family

ID=36190792

Family Applications (1)

Application Number Title Priority Date Filing Date
PL06291423T PL1762238T3 (pl) 2005-09-09 2006-09-08 Połączenie agomelatyny z regulatorem nastroju oraz zawierające je kompozycje farmaceutyczne

Country Status (38)

Country Link
US (1) US7902180B2 (pl)
EP (2) EP1762238B1 (pl)
JP (1) JP2007077149A (pl)
KR (2) KR20070029607A (pl)
CN (1) CN1927194A (pl)
AP (1) AP3045A (pl)
AR (1) AR055418A1 (pl)
AT (1) ATE519482T1 (pl)
AU (1) AU2006209371B2 (pl)
BR (1) BRPI0603767A (pl)
CA (1) CA2558764C (pl)
CY (1) CY1112223T1 (pl)
DK (1) DK1762238T3 (pl)
EA (1) EA014381B1 (pl)
ES (1) ES2371482T3 (pl)
FR (1) FR2890563B1 (pl)
GE (1) GEP20094741B (pl)
GT (1) GT200600410A (pl)
HR (1) HRP20110749T1 (pl)
JO (1) JO2746B1 (pl)
MA (1) MA28504B1 (pl)
ME (1) ME01964B (pl)
MX (1) MXPA06010234A (pl)
MY (1) MY162318A (pl)
NO (1) NO338079B1 (pl)
NZ (1) NZ549727A (pl)
PE (1) PE20070613A1 (pl)
PL (1) PL1762238T3 (pl)
PT (1) PT1762238E (pl)
RS (1) RS52003B (pl)
SA (1) SA110320045B1 (pl)
SG (1) SG131029A1 (pl)
SI (1) SI1762238T1 (pl)
TW (1) TWI369980B (pl)
UA (1) UA83541C2 (pl)
UY (1) UY29776A1 (pl)
WO (1) WO2007028903A1 (pl)
ZA (1) ZA200607532B (pl)

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2658818B1 (fr) 1990-02-27 1993-12-31 Adir Cie Nouveaux derives a structure naphtalenique, leur procede de preparation et les compositions pharmaceutiques qui les contiennent.
CZ20013786A3 (cs) * 1999-04-29 2002-02-13 Merck Patent Gmbh Inhibitory glycinového ątěpicího systému jako moľná antipsychotika
CN100525761C (zh) * 1999-12-01 2009-08-12 Ucb公司 用于治疗cns疾病的吡咯烷乙酰胺衍生物或者其组合物
AR047553A1 (es) * 2003-07-04 2006-01-25 Lundbeck & Co As H La combinacion de un inhibidor de reabsorcion de serotonina y agomelatina
FR2884714B1 (fr) * 2005-04-20 2011-05-06 Servier Lab Utilisation de l'agomelatine pour l'obtention de medicaments destines au traitement des troubles bipolaires

Also Published As

Publication number Publication date
US20070066689A1 (en) 2007-03-22
UY29776A1 (es) 2006-11-30
SG131029A1 (en) 2007-04-26
EP1762238A1 (fr) 2007-03-14
JP2007077149A (ja) 2007-03-29
PE20070613A1 (es) 2007-07-30
EA014381B1 (ru) 2010-10-29
AR055418A1 (es) 2007-08-22
MA28504B1 (fr) 2007-04-03
MXPA06010234A (es) 2007-03-08
AU2006209371A1 (en) 2007-03-29
SI1762238T1 (sl) 2011-10-28
FR2890563A1 (fr) 2007-03-16
UA83541C2 (uk) 2008-07-25
NO338079B1 (no) 2016-07-25
ATE519482T1 (de) 2011-08-15
NO20064049L (no) 2007-03-12
EP1762238B1 (fr) 2011-08-10
PT1762238E (pt) 2011-09-01
WO2007028903A1 (fr) 2007-03-15
AP3045A (en) 2014-11-30
CN1927194A (zh) 2007-03-14
GT200600410A (es) 2007-05-21
CY1112223T1 (el) 2015-12-09
AP2008004380A0 (en) 2008-04-30
ES2371482T3 (es) 2012-01-03
TW200800860A (en) 2008-01-01
RS52003B (en) 2012-04-30
JO2746B1 (en) 2014-03-15
SA110320045B1 (ar) 2014-01-29
CA2558764A1 (fr) 2007-03-09
KR20090056949A (ko) 2009-06-03
FR2890563B1 (fr) 2007-10-19
CA2558764C (fr) 2013-01-08
TWI369980B (en) 2012-08-11
AU2006209371B2 (en) 2012-02-02
ME01964B (me) 2012-04-30
BRPI0603767A (pt) 2007-08-14
DK1762238T3 (da) 2011-11-07
MY162318A (en) 2017-05-31
HRP20110749T1 (hr) 2011-11-30
EP2301527A1 (fr) 2011-03-30
US7902180B2 (en) 2011-03-08
ZA200607532B (en) 2008-05-28
KR20070029607A (ko) 2007-03-14
EA200601450A1 (ru) 2007-04-27
NZ549727A (en) 2008-03-28
GEP20094741B (en) 2009-07-27

Similar Documents

Publication Publication Date Title
IL242883B (en) Aryl-amino and heteroaryl-amino converted deoxazolines and pharmaceutical preparations containing them
IL223477A (en) Pharmaceutical preparation containing modified enzyme uricase
IL190292A (en) History of pyridopyrimidinone and their pharmaceutical preparations
PL1951838T3 (pl) Kompozycje zawierające fluoroolefiny i ich zastosowania
EP1857489A4 (en) MICROPARTICLE AND PHARMACEUTICAL COMPOSITION
IL192845A0 (en) Benzamide and heteroarene derivatives
EP1861387A4 (en) NOVEL BENZOIMIDAZOLE DERIVATIVES AND PHARMACEUTICAL COMPOSITION CONTAINING SAME
EP1909780A4 (en) AGAINST TUBERCULOSIS, COMPOSITIONS AND PROCEDURES
HK1128487A1 (en) Compositions comprising fluoroolefins and uses thereof
EP2056835A4 (en) PHARMACEUTICAL COMPOSITIONS AND USES THEREOF
ZA200710817B (en) Benzamide derivatives and uses related thereto
HK1112427A1 (en) Drug delivery compositions and related methods
EP1890677A4 (en) PHARMACEUTICAL COMPOSITIONS AND THEIR USE
GB0516069D0 (en) Pharmaceutical and use thereof
IL196136A (en) Its aminoindane or salt derivative, the pharmaceutical composition containing them and their uses
IL193211A (en) Derivatives of Indzol-Troaril and pharmaceutical preparations containing them
EP1848438A4 (en) DIAMINOPHENOTHIAZINE COMPOSITIONS AND THEIR USE
EP1884510A4 (en) N-SUBSTITUTED PHENYLACETAMIDE DERIVATIVE AND PHARMACEUTICAL COMPOSITION CONTAINING SAME
EP1951671A4 (en) NEW PULLEOMUTILINE DERIVATIVES AND THEIR USE
GB0614365D0 (en) Pharmaceutical compositions and their use
HK1108636A1 (en) Substituted acrylamide derivative and pharmaceutical composition comprising the same
IL186337A0 (en) Stannsoporfin compositions and administration
HK1145837A1 (en) Amide derivative and pharmaceutical composition containing the same
TWI371272B (en) Substituted propanamide derivatives and pharmaceutical compositions thereof
EP1937292A4 (en) LOPAP-BASED PHARMACEUTICAL COMPOSITIONS AND USES THEREOF